{"data":[{"accessionNo":"0002012383-26-003187","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4122510,"percentOfClass":7.7,"filedAt":"2026-07-30"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000905148-26-002424","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":"37611X209","securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":3577128,"percentOfClass":7.1,"filedAt":"2026-05-15"},{"accessionNo":"0000102909-26-001330","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings Inc","ticker":"DNA","cusip":"37611X209","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0001088875-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"BAILLIE GIFFORD & CO","reportingCik":null,"personType":"IA","sharesOwned":2391649,"percentOfClass":4.9,"filedAt":"2026-02-05"},{"accessionNo":"0001104659-25-112557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Cascade Investment, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3621636,"percentOfClass":7.5,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-112557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001830214","issuerName":"Ginkgo Bioworks Holdings, Inc.","ticker":"DNA","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"William H. Gates III","reportingCik":null,"personType":"IN","sharesOwned":3621636,"percentOfClass":7.5,"filedAt":"2025-11-14"}],"updatedAt":"2026-10-13T08:34:24.538Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}